The Procter & Gamble Company (PG): Was This The Dumbest Stock Pick at The Ira Sohn?

The Ira Sohn conference invites a number of well-known investment managers to give public presentations of their favorite investing ideas. This year, billionaire Bill Ackman of Pershing Square- except for a brief reference to his last public presentation, when he recommended shorting Herbalife Ltd. (NYSE:HLF) – focused on the long case for The Procter & Gamble Company (NYSE:PG). We think that this was a highly questionable pick. Ackman’s interest in The Procter & Gamble Company (NYSE:PG) is well known; in fact, about a year ago he reported to investors that Pershing Square had sold out of Citigroup Inc (NYSE:C) in order to buy shares of the personal products company. The fund bought nearly 22 million shares of The Procter & Gamble Company (NYSE:PG) during the second quarter of 2012, according to SEC filings (research more of Ackman’s long positions over time), for a position of $1.3 billion. Pershing Square has since added some shares. At the time, we estimated that the fund had lost nearly $400 million on its Citigroup investment (read our coverage of Ackman’s trade).

The average price of The Procter & Gamble Company (NYSE:PG) during Q2 2012 looks to have been about $64. At a current price of $78, then, Ackman has indeed generated profits with a 22% gain. However, these results have essentially matched those of the S&P 500 and so his decision to go long The Procter & Gamble Company (NYSE:PG) is not necessarily that admirable. In addition, Citigroup (along with many other large banks) have been on a tear in the last year with that stock in particular up over 50%. Pershing Square didn’t just lose money on Citi while the fund owned it- Ackman and his team sold out of the stock near the bottom in exchange for a consumer staples stock which has only performed in line with the market.

PERSHING SQUAREIf we assume that Pershing Square sold Citigroup at about $30 per share- which looks to be about its Q2 midpoint- then the fund has missed out on a 64% return or $19 per share x 26 million shares = about $500 million. It has earned, by our reckoning, $14 per share x 22 million shares = about $310 million shares in The Procter & Gamble Company (NYSE:PG), but that still leaves Pershing Square about $200 million short- which would represent $40 million in carried interest- even with the fund investing more capital in Procter & Gamble than it did in Citigroup. In other words, Ackman is already “in the red” in his decision to dump Citigroup and buy P&G.

Ackman’s argument for Procter & Gamble as not only a market-beating stock, but as his best idea, also seems unpersuasive. The manager has already criticized the company’s management for underperformance and efficiency, but aside from a suggestion that the CEO vacate some of the many Boards of Directors he is a member of Ackman’s own ideas for improvement were limited. In addition, we’d imagine that the opportunities for activist pressure are limited at a company with a market cap of over $200 billion.

Procter & Gamble currently trades at 18 times earnings, whether we consider its trailing results or analyst expectations for the fiscal year ending in June 2014. Net income was up 6% in its most recent quarter compared to the same period in the previous year, but this was primarily due to higher net margins as revenue grew by only 2%. We don’t expect the company to be able to continually increase its margins, so over time earnings growth should match revenue growth and going by last quarter’s numbers it’s not clear that earnings will rise enough to make the stock a value at these levels. It’s possible that P&G is a better value than peer Johnson & Johnson (NYSE:JNJ), which carries a trailing earnings multiple of 23, but it’s difficult to see it as a good value in absolute terms let alone one of the best opportunities in the market.

Ackman has made some excellent picks at investing conferences in the past (including his long recommendation for General Growth Properties Inc (NYSE:GGP) four years ago) but his move into Procter & Gamble has not done well in the last year compared to the market or to the stock it replaced in Pershing Square’s portfolio. The company also doesn’t look too attractive right now, and so we would advise against following the fund into P&G.

Disclosure: I own no shares of any stocks mentioned in this article.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 High Margin Food Products to Build a Business Around

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

The 10 Most Expensive Boarding Schools In the World

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

Top 6 Cities For The Ultra Rich to Live in Comfort

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!